ME, short for myalgic encephalomyelitis, is a chronic illness that severely limits the body’s ability to produce and use energy. Often grouped under the name ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome), it affects roughly 1.3% of American adults, and the true number is likely higher since many people remain undiagnosed. The defining feature isn’t ordinary tiredness. It’s a measurable breakdown in how cells generate energy, combined with a characteristic crash after even minor physical or mental effort.
Core Symptoms and How It’s Diagnosed
A diagnosis requires three symptoms that have persisted for at least six months. First, a substantial drop in your ability to do what you could before you got sick, whether that’s work, school, socializing, or basic daily tasks. This drop is accompanied by fatigue that is new (not lifelong), not caused by unusual exertion, and not relieved by rest. Second, post-exertional malaise, meaning your symptoms get worse after physical, mental, or emotional effort that wouldn’t have been a problem before. Third, unrefreshing sleep: a full night of rest doesn’t leave you feeling restored.
On top of those three, at least one additional symptom is required. That’s either cognitive impairment (problems with memory, focus, processing speed, and executive function, sometimes called “brain fog”) or orthostatic intolerance, where symptoms worsen when you stand or sit upright for any length of time. To qualify, these symptoms need to be present at least half the time at a moderate or greater intensity.
What’s Happening Inside the Body
Healthy cells produce energy through a process that relies on oxygen and takes place inside mitochondria, the small structures within every cell that act as power generators. In people with ME, this system appears to be impaired. Studies using specialized imaging of skeletal muscle have found lower rates of energy (ATP) production during exercise recovery, along with increased acidity inside cells, a sign that the body is relying on a less efficient, oxygen-free backup system to generate power.
Researchers at the National Institutes of Health identified a specific protein, encoded by a gene called WASF3, that is overproduced in the muscle tissue of ME patients. When this protein is elevated, it destabilizes key components of the mitochondrial energy chain and forces cells to shift toward that less efficient backup pathway. Mice engineered to overproduce the same protein showed significantly reduced exercise capacity and higher blood lactate levels, mimicking the exercise intolerance seen in humans with the disease.
This cellular energy deficit helps explain why exertion causes such disproportionate crashes. In healthy people, exercise triggers blood vessels to widen and improves circulation. In ME, the opposite can happen. Physical activity appears to increase oxidative stress, a form of molecular damage caused by unstable molecules called free radicals, rather than reducing it. Over time, chronic oxidative stress damages the lining of blood vessels and promotes inflammation, which may be why even small amounts of activity can trigger symptom flares lasting hours or days.
Post-Exertional Malaise: The Hallmark Symptom
Post-exertional malaise (PEM) is what most clearly distinguishes ME from other conditions that cause fatigue. It’s not simply feeling tired after doing too much. PEM is a systemic worsening of all symptoms, including pain, cognitive problems, and flu-like feelings, triggered by effort that would have been trivial before the illness. A short grocery trip, a phone call, or a stressful conversation can be enough. The crash often doesn’t peak until 24 to 72 hours after the triggering activity, making it hard to connect cause and effect, and recovery can take days or weeks.
Because of this pattern, the primary management strategy is called pacing: carefully staying within your energy limits to avoid triggering PEM in the first place. This means planning activities, resting before you feel exhausted, and accepting a narrower range of daily effort than you’re used to. Graded exercise therapy, which once encouraged patients to gradually increase their activity levels, has been largely abandoned in updated clinical guidelines because pushing through PEM tends to make the condition worse, not better.
Who Gets ME
CDC data from 2021 to 2022 shows that women are roughly twice as likely as men to be diagnosed, at 1.7% compared to 0.9%. The condition becomes more common with age, peaking between 50 and 69 (around 2% of adults in that range) before declining slightly after 70. White non-Hispanic adults have the highest reported rates at 1.5%, followed by Black non-Hispanic adults at 1.2%, though diagnostic access likely influences these numbers.
Income and geography also play a role. Adults living below the federal poverty level are nearly twice as likely to have ME as those at higher incomes (2.0% versus 1.1%). Rates are also higher in rural areas (1.9%) compared to large metropolitan areas (1.0%), a gap that may reflect differences in occupational demands, healthcare access, or environmental exposures.
ME in Children and Teenagers
ME occurs less often in children under 10, partly because younger kids may struggle to describe changes in their energy levels and activity. In older children and adolescents, girls are affected far more than boys, with ratios ranging from 2:1 to as high as 6:1 depending on the study. Some guidelines recommend diagnosing children after three months of symptoms rather than the six months required for adults, recognizing that early intervention matters during critical developmental years.
On standard cognitive tests, children with ME often perform similarly to healthy peers. But when testing conditions become more complex, particularly when combining mental tasks with standing (which stresses the cardiovascular system), impairments become apparent. The prognosis for children is generally described as better than for adults, though long-term follow-up studies are limited and full recovery is far from guaranteed.
The Economic and Personal Cost
The financial toll of ME is enormous. Lost productivity alone has been estimated at $9.1 billion annually in the United States, roughly $20,000 per person per year. When combined with direct medical costs, total estimates range from $18.7 billion to $24 billion per year. These figures capture only part of the picture. Many people with ME are unable to work at all, and the informal caregiving burden on families goes largely uncounted.
Beyond money, the illness reshapes daily life in ways that are hard to convey with statistics. People with moderate to severe ME may be unable to leave their homes. Those with the most severe forms are bedbound in darkened rooms, unable to tolerate light, sound, or conversation. The gap between how the disease looks from the outside (a person who seems fine but “just doesn’t do much”) and the biological reality of damaged cellular energy production has historically fueled stigma and delayed both diagnosis and research funding.